Fig. 3From: Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinomaPrognostic power of the risk assessment model. Risk score (A) and survival outcome (B) of each case. Kaplan-Meier survival curve of the high-risk group and low-risk group (C)Back to article page